1-3 of 3
Steffen Koschmieder
Close
Sort by
Journal Articles

Germline variants in DNA repair genes, including BRCA1 / 2 , may cause familial myeloproliferative neoplasms

Clinical Trials & Observations
Miriam Elbracht, Robert Meyer, Kim Kricheldorf, Deniz Gezer, Eggermann Thomas, Beate Betz, Ingo Kurth, Lino L. Teichmann, Tim H. Brümmendorf, Ulrich Germing, Susanne Isfort, Steffen Koschmieder
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3373–3376.
https://doi.org/10.1182/bloodadvances.2021004811
Published: 2021
Journal Articles

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

Clinical Trials & Observations
Vikas Gupta, Denise Wolleschak, Hans Hasselbalch, Alessandro Maria Vannucchi, Steffen Koschmieder, Francisco Cervantes, Yang Li, Tuochuan Dong, Monika Wroclawska, Savita Bharathy, Claire Harrison
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3063–3071.
https://doi.org/10.1182/bloodadvances.2019001212
Published: 2020
Includes: Supplemental data
Journal Articles

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia

Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus, Volker Kunzmann, Jolanta Dengler, Jeroen Janssen, Gert Ossenkoppele, Peter E. Westerweel, Peter A. W. te Boekhorst, Francois-Xavier Mahon, Henrik Hjorth-Hansen, Susanne Isfort, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, Stefan Wilop, Steffen Koschmieder, Susanne Saußele, Satu Mustjoki, Fabian Beier, Tim H. Brümmendorf
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1572–1579.
https://doi.org/10.1182/bloodadvances.2018017772
Published: 2018
Includes: Supplemental data